First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate

D J Lamprecht

doi:10.7196/

PDF

Published: 2025-09-04

DOI: https://doi.org/10.7196/

Keywords:

first line treatment, methotrexate

D J Lamprecht

Pulmonology Fellow, University of the Witwatersrand and Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa

Abstract

Downloads

Download data is not yet available.

Issue

AJTCCM Vol. 31 No. 3

Section

Breath-Taking News

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.

Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.

How to Cite

Lamprecht DJ. First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate. Afr J Thoracic Crit Care Med [Internet]. 2025 Sep. 4 [cited 2025 Oct. 2];31(3):e4189. Available from: https://samajournals.co.za/index.php/ajtccm/article/view/4189

References

1. Dhooria S, Singh Sehgal I, Agarwal R, et al. High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: A randomised trial (SARCORT trial). Eur Respir J 2023;62(3):2300198. https://doi.org/10.1183/13993003.00198-2023

2. Kahlmann V, Janssen Bonás M, Moor CC, et al. First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate. N Engl J Med 2025;393(3):231-242. https://doi.org/10.1056/NEJMoa2501443

3. ick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006;55(1):19-26. https://doi. org/10.1002/art.21705

Announcements

Submission guidelines

First time authors, please follow the guidelines above on how to submit the manuscript on the AJTCCM submission portal.

For guidelines on general manuscript preparation, please click here: General formatting guidelines

For information on how to prepare specific article types, please refer to the relevant section under the drop-down Author Guidelines menu.

AJTCCM News

Accreditation

The African Journal of Thoracic and Critical Care Medicine is now SA DoHET-accredited, Scopus-indexed and indexed with NCBI databases including PubMed Central.

Editorial board

Editor-in-chief

Prof K Dheda, MB BCh (Wits), FCP(SA), FCCP, PhD (Lond), FRCP (Lond). Head Department the Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Professor of Mycobacteriology and Global Health, London School of Hygiene and Tropical Medicine, London, United Kingdom; Director, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, South Africa.

Deputy Editor

Prof C Koegelenberg, MB ChB, MMed (Int), FCP (SA), MRCP (UK), Cert Pulm (SA), PhD. Senior Specialist: Pulmonology & General Medicine, University of Stellenbosch & Tygerberg Academic Hospital, South Africa.

Section Editor: Breath-taking News

Prof E M Irusen, MB ChB, FCP(SA), PhD. Head: Division of Pulmonology Department of Medicine Faculty of Health Sciences University of Stellenbosch & Tygerberg Academic Hospital, South Africa.

President SA Thoracic Society

Prof. R Masekela, MB BCh, MMed (Paeds)Pret, Dipl Allerg (SA), PhD, FCCP. Adjunct Professor, Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, South Africa.
Expertise: Paediatrics, asthma, chronic lung disease, epidemiology

Article Sidebar

Main Article Content